Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Carcinoid tumor in the urinary bladder: unreported features.
Baydar DE, Tasar C.
Am J Surg Pathol. 2011 Nov;35(11):1754-7. No abstract available.
Related citations
Identification of Gleason pattern 5 on prostatic needle core biopsy: frequency of underdiagnosis and relation to morphology.
Fajardo DA, Miyamoto H, Miller JS, Lee TK, Epstein JI.
Am J Surg Pathol. 2011 Nov;35(11):1706-11.
Cervical-type squamous metaplasia and myoepithelial cell differentiation in stromal tumor of the prostate.
Montironi R, Lopez-Beltran A, Cheng L, Scarpelli M.
Am J Surg Pathol. 2011 Nov;35(11):1752-4. No abstract available.
Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
Karram S, Trock BJ, Netto GJ, Epstein JI.
Am J Surg Pathol. 2011 Sep;35(9):1351-5.
Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.
Al-Hussain TO, Epstein JI.
Am J Surg Pathol. 2011 Aug;35(8):1165-7.
Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.
Chaux A, Albadine R, Toubaji A, Hicks J, Meeker A, Platz EA, De Marzo AM, Netto GJ.
Am J Surg Pathol. 2011 Jul;35(7):1014-20.
The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Yaskiv O, Zhang X, Simmerman K, Daly T, He H, Falzarano S, Chen L, Magi-Galluzzi C, Zhou M.
Am J Surg Pathol. 2011 Jul;35(7):1062-8.
Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB, Fine SW, Epstein JI.
Am J Surg Pathol. 2011 Jul;35(7):1054-61.
Epithelial proliferations in prostatic stromal tumors of uncertain malignant potential (STUMP).
Nagar M, Epstein JI.
Am J Surg Pathol. 2011 Jun;35(6):898-903.
The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H, Magi-Galluzzi C, Li J, Carver P, Falzarano S, Smith K, Rubin MA, Zhou M.
Am J Surg Pathol. 2011 Apr;35(4):608-14.
Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.
Amin A, Epstein JI.
Am J Surg Pathol. 2011 Apr;35(4):615-9.
Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases.
Chen YB, Epstein JI.
Am J Surg Pathol. 2011 Mar;35(3):442-6.
ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.
Miettinen M, Wang ZF, Paetau A, Tan SH, Dobi A, Srivastava S, Sesterhenn I.
Am J Surg Pathol. 2011 Mar;35(3):432-41.
Prostate cancer topography and patterns of lymph node metastasis.
Tokuda Y, Carlino LJ, Gopalan A, Tickoo SK, Kaag MG, Guillonneau B, Eastham JA, Scher HI, Scardino PT, Reuter VE, Fine SW.
Am J Surg Pathol. 2010 Dec;34(12):1862-7.
NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM.
Am J Surg Pathol. 2010 Aug;34(8):1097-105.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on